← Eichor
Study identifier: NCT05756985 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Condition: Glioblastoma · Glioblastoma Multiforme · Gliosarcoma  ·  Sponsor: Baptist Health South Florida

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.

This description comes directly from the study's public registry record.

Talk to the study team

Manmeet S Ahluwalia, M.D.  ·  (786) 596-2000  ·  manmeeta@baptisthealth.net

Michael McDermott, M.D.  ·  (786) 596-2000  ·  MWMCD@baptisthealth.net

Always discuss trial participation with your own doctor first.

Locations (1)

Miami Cancer Institute at Baptist Health, Inc.Miami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05756985